These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34765739)

  • 21. Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars.
    Perez JL; Jayaprakasha GK; Patil BS
    Food Chem; 2019 Aug; 288():178-186. PubMed ID: 30902279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of bitter melon (Momordica charantia) cultivars grown in Texas and levels of various phytonutrients.
    Perez JL; Jayaprakasha GK; Crosby K; Patil BS
    J Sci Food Agric; 2019 Jan; 99(1):379-390. PubMed ID: 29888551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First Report of Pseudoperonospora cubensis Causing Downy Mildew on Momordica balsamina and M. charantia in North Carolina.
    Wallace E; Adams M; Ivors K; Ojiambo PS; Quesada-Ocampo LM
    Plant Dis; 2014 Sep; 98(9):1279. PubMed ID: 30699625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First report of zucchini yellow mosaic virus infecting bitter melon (Momordica charantia) in South Korea.
    Lee HJ; Cho IS; Jeong RD
    Plant Dis; 2022 Jan; ():. PubMed ID: 35072507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
    Fuangchan A; Sonthisombat P; Seubnukarn T; Chanouan R; Chotchaisuwat P; Sirigulsatien V; Ingkaninan K; Plianbangchang P; Haines ST
    J Ethnopharmacol; 2011 Mar; 134(2):422-8. PubMed ID: 21211558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo anticancer effects of Momordica charantia seed fat on hepatocellular carcinoma in a rat model.
    Ranasinghe KNK; Premarathna AD; Mahakapuge TAN; Wijesundera KK; Ambagaspitiya AT; Jayasooriya AP; Kularatne SAM; Rajapakse RPVJ
    J Ayurveda Integr Med; 2021; 12(3):435-442. PubMed ID: 34275705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
    Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y
    J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
    Brennan VC; Wang CM; Yang WH
    J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
    Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
    Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (
    Hussain L; Aamir N; Hussain M; Asif M; Chauhdary Z; Manzoor F; Siddique R; Riaz M
    Evid Based Complement Alternat Med; 2022; 2022():5143653. PubMed ID: 36212951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
    Yaldız G; Sekeroglu N; Kulak M; Demirkol G
    Nat Prod Res; 2015; 29(6):543-5. PubMed ID: 25141891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory Effects of
    Rao CV
    Cancer Prev Res (Phila); 2018 Apr; 11(4):185-186. PubMed ID: 29559516
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Peeran SW; Murugan M; Fageeh H; Ibrahim W; Al-Ak'hali MS; Basheer SN; Mohamed AMB
    J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1554-S1564. PubMed ID: 38882883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Bitter Melon in Breast and Gynecological Cancer Prevention and Therapy.
    Psilopatis I; Vrettou K; Giaginis C; Theocharis S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240264
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Çiçek SS
    Front Pharmacol; 2022; 13():904643. PubMed ID: 35656300
    [No Abstract]   [Full Text] [Related]  

  • 37. Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia).
    Cuong DM; Jeon J; Morgan AMA; Kim C; Kim JK; Lee SY; Park SU
    J Agric Food Chem; 2017 Aug; 65(33):7240-7249. PubMed ID: 28737900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Butanol Fraction of Bitter Melon (Momordica charantia) Scavenges Free Radicals and Attenuates Oxidative Stress.
    Kim HY; Sin SM; Lee S; Cho KM; Cho EJ
    Prev Nutr Food Sci; 2013 Mar; 18(1):18-22. PubMed ID: 24471105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mining the bitter melon (momordica charantia l.) seed transcriptome by 454 analysis of non-normalized and normalized cDNA populations for conjugated fatty acid metabolism-related genes.
    Yang P; Li X; Shipp MJ; Shockey JM; Cahoon EB
    BMC Plant Biol; 2010 Nov; 10():250. PubMed ID: 21080948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of Biological Activities of Wild Bitter Melon (
    Pham TMH; Ngo DH; Ngo DN; Vo TS
    Biomolecules; 2019 May; 9(6):. PubMed ID: 31151277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.